Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04037969
Other study ID # 41195
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 7, 2019
Est. completion date November 26, 2019

Study information

Verified date March 2021
Source University of Waterloo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot study is to compare the effect of DAILIES TOTAL1, a low water content silicone hydrogel lens, and Biotrue ONEday, a high water content hydrogel lens, on the rate of tear evaporation. The study will also serve to validate the novel, in-house developed evaporimeter.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date November 26, 2019
Est. primary completion date November 26, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 17 Years and older
Eligibility Inclusion Criteria: 1. Is at least 17 years of age and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. Has worn soft contact lenses for a minimum of 6 months; 5. Currently wears soft contact lenses for at least 4 days per week and 8 hours per day; 6. Has an acceptable fit and comfort with both study contact lenses in the powers available; 7. Has less than or equal to 1.00DS difference between eyes in their habitual contact lenses; 8. Is willing to be awake for at least 2 hours before visit 2; 9. Is willing to not wear eye makeup on the day of visit 2 and 3; 10. Is willing to not use eye drops or artificial tears on the day of visits 1, 2, and 3; 11. Has a wearable pair of spectacles. Exclusion Criteria: 1. Is participating in any concurrent clinical or research study; 2. Has any known active* ocular disease and/or infection; 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 5. Has known sensitivity to sodium fluorescein dye; 6. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit); 7. Is aphakic; 8. Has undergone refractive error surgery; 9. Has a known sensitivity to petroleum jelly (Vaseline); 10. Has epilepsy and/or a sensitivity to flashing lights; 11. Wears toric contact lenses; 12. Has any physical impairment that would interfere with holding the evaporimeter; 13. Has taken part in another research study within the last 14 days.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nesofilcon A
Hydrogel contact lens for daily wear
Delefilcon A
Silicone hydrogel contact lens for daily wear

Locations

Country Name City State
Canada Centre for Ocular Research & Education Waterloo Ontario

Sponsors (1)

Lead Sponsor Collaborator
University of Waterloo

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tear Evaporation Rate With Nesofilcon A Tear film evaporation rate (% relative humidity per second) was performed using a novel evaporimeter as a non-invasive measurement of tear film evaporation. The slope was calculated from the change in humidity between 7 to 17.5 seconds while the eye was open and between 10 to 17.5 seconds when the eye was closed. Data from the both eyes were analyzed. Baseline, 15 minutes post-contact lens, 6 hours post-contact lens
Primary Tear Evaporation Rate With Delefilcon A Tear film evaporation rate (% relative humidity per second) was performed using a novel evaporimeter as a non-invasive measurement of tear film evaporation. The slope was calculated from the change in humidity between 7 to 17.5 seconds while the eye was open and between 10 to 17.5 seconds when the eye was closed. Data from the both eyes were analyzed. Baseline, 15 minutes post-contact lens, 6 hours post-contact lens
See also
  Status Clinical Trial Phase
Completed NCT06176651 - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Phase 4
Completed NCT04091581 - Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye Phase 4
Active, not recruiting NCT04608942 - Refractory Meibomian Gland Dysfunction and Plasma Jet N/A
Completed NCT03055897 - Tear Film Innovations iLux Safety Study N/A
Completed NCT05536661 - Impact of Tear Substitute Use on Dry Eye in Gamers. N/A
Completed NCT04658927 - Dextenza With ILUX for Treatment of MGD Phase 4
Not yet recruiting NCT04711642 - Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery Phase 3
Completed NCT03055650 - iLux Treatment for Meibomian Gland Dysfunction (MGD) N/A
Not yet recruiting NCT06158997 - Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease N/A
Completed NCT05331924 - Quality of Life Improvement in Dry Eye Patients After Intense Pulsed Light Therapy Compared to Punctal Plugs N/A